| 1. |
|
Chu Ching-Tung, Uruno Akira, Suzuki Takafumi, et al. NRF2 activation by CDDO-Im regulates inflammatory and autophagy pathways in human microglial cells. Free Radical Biology and Medicine. 2026; 243 : 318-337. doi:10.1016/j.freeradbiomed.2025.11.046 |
|
| 2. |
|
Ang Abel D, Dayalan Naidu Sharadha, Read Oliver J, et al. The CNC-bZIP transcription factor Nrf2 controls expression of matrix metalloproteases in murine macrophages. Journal of Leukocyte Biology. 2026; 118 (3): . doi:10.1093/jleuko/qiag021 |
|
| 3. |
|
Feng Jialin, Carreño Mara, Jung Hannah, et al. The electrophilic metabolite of kynurenine, kynurenine-CKA, requires C151 in Keap1 to derepress Nrf2. Redox Biology. 2026; 90 : 104009. doi:10.1016/j.redox.2026.104009 |
|
| 4. |
|
Dayalan Naidu Sharadha, Dikovskaya Dina, Walker Jasmine M., et al. Keap1-Kelch-targeting protein–protein interaction inhibitors, but not reversibly-binding electrophiles, increase the thermostability of Keap1 in the cellular environment. RSC Chemical Biology. 2026; 7 (5): 906-922. doi:10.1039/D6CB00045B |
|
| 5. |
|
Tsuji Ryosuke, Fujita Ryo, Hayashi Takuto, et al. 0.33 g mitigates muscle atrophy while 0.67 g preserves muscle function and myofiber type composition in mice during spaceflight. Science Advances. 2026; 12 (11): . doi:10.1126/sciadv.aed2258 |
|
| 6. |
|
Dayalan Naidu Sharadha, Ang Abel D., Jia Yee Charlotte Lim, et al. CD5L is a target of transcription factor Nrf2. Biochemical and Biophysical Research Communications. 2025; 776 : 152225. doi:10.1016/j.bbrc.2025.152225 |
|
| 7. |
|
Aoyama Yumi, Yamazaki Hiromi, Nishimura Koutarou, et al. Selenoprotein-mediated redox regulation shapes the cell fate of HSCs and mature lineages. Blood. 2025; 145 (11): 1149-1163. doi:10.1182/blood.2024025402 |
|
| 8. |
|
Baird Liam, Zhang Lin, Hidaka Takanori, et al. Systemic activation of NRF2 contributes to the therapeutic efficacy of clinically-approved KRAS-G12C anti-cancer drugs. British Journal of Cancer. 2025; 133 (9): 1377-1390. doi:10.1038/s41416-025-03162-7 |
|
| 9. |
|
Wen Huaichun, Suzuki Takafumi, Zhang Anqi, et al. NRF2 activation in cancer cells suppresses immune infiltration into the tumor microenvironment. iScience. 2025; 28 (10): 113519. doi:10.1016/j.isci.2025.113519 |
|
| 10. |
|
Katsuoka Fumiki, Kawashima Junko, Tadaka Shu, et al. Advancements in Whole-Genome Sequencing Protocols: A Decade of In-House Operations and Quality Controls at the Tohoku Medical Megabank. JMA Journal. 2025; 8 (4): . doi:10.31662/jmaj.2025-0159 |
|
| 11. |
|
Suzuki Takafumi, Takagi Kenji, Iso Tatsuro, et al. Bidirectional regulation of KEAP1 BTB domain-based sensor activity. Redox Biology. 2025; 87 : 103885. doi:10.1016/j.redox.2025.103885 |
|
| 12. |
|
Iwasaki Tomoyuki, Shirota Hidekazu, Sasaki Keiju, et al. Specific cancer types and prognosis in patients with variations in the KEAP1 ‐ NRF2 system: A retrospective cohort study. Cancer Science. 2024; 115 (12): 4034-4044. doi:10.1111/cas.16355 |
|
| 13. |
|
Takahashi Jun, Suzuki Takafumi, Sato Miu, et al. Differential squamous cell fates elicited by NRF2 gain of function versus KEAP1 loss of function. Cell Reports. 2024; 43 (4): 114104. doi:10.1016/j.celrep.2024.114104 |
|
| 14. |
|
Ikejiri Kazuaki, Suzuki Takafumi, Muto Satsuki, et al. Effects of NRF2 polymorphisms on safety and efficacy of bardoxolone methyl: subanalysis of TSUBAKI study. Clinical and Experimental Nephrology. 2024; 28 (3): 225-234. doi:10.1007/s10157-023-02427-w |
|
| 15. |
|
Sato Miu, Yaguchi Nahoko, Iijima Takuya, et al. Sensor systems of KEAP1 uniquely detecting oxidative and electrophilic stresses separately In vivo. Redox Biology. 2024; 77 : 103355. doi:10.1016/j.redox.2024.103355 |
|
| 16. |
|
Uruno Akira, Kadoguchi-Igarashi Shiori, Saito Ritsumi, et al. The NRF2 inducer CDDO-2P-Im provokes a reduction in amyloid β levels in Alzheimer’s disease model mice. The Journal of Biochemistry. 2024; 176 (5): 405-414. doi:10.1093/jb/mvae060 |
|
| 17. |
|
Aoki Yu-ichi, Taguchi Keiko, Anzawa Hayato, et al. Whole blood transcriptome analysis for age- and gender-specific gene expression profiling in Japanese individuals. The Journal of Biochemistry. 2024; 175 (6): 611-627. doi:10.1093/jb/mvae008 |
|
| 18. |
|
Shimizu Ritsuko, Hirano Ikuo, Hasegawa Atsushi, et al. Nrf2 alleviates spaceflight-induced immunosuppression and thrombotic microangiopathy in mice. Communications Biology. 2023; 6 (1): 875. doi:10.1038/s42003-023-05251-w |
|
| 19. |
|
Zhang Anqi, Suzuki Takafumi, Adachi Saki, et al. Nrf2 activation improves experimental rheumatoid arthritis. Free Radical Biology and Medicine. 2023; 207 : 279-295. doi:10.1016/j.freeradbiomed.2023.07.016 |
|
| 20. |
|
Suzuki Takafumi, Takahashi Jun, Yamamoto Masayuki. Molecular Basis of the KEAP1-NRF2 Signaling Pathway. Molecules and Cells. 2023; 46 (3): 133-141. doi:10.14348/molcells.2023.0028 |
|
| 21. |
|
Baird Liam, Taguchi Keiko, Zhang Anqi, et al. A NRF2-induced secretory phenotype activates immune surveillance to remove irreparably damaged cells. Redox Biology. 2023; 66 : 102845. doi:10.1016/j.redox.2023.102845 |
|
| 22. |
|
Suzuki Norio, Iwamura Yuma, Nakai Taku, et al. Gene expression changes related to bone mineralization, blood pressure and lipid metabolism in mouse kidneys after space travel. Kidney International. 2022; 101 (1): 92-105. doi:10.1016/j.kint.2021.09.031 |
|
| 23. |
|
Uruno Akira, Saigusa Daisuke, Suzuki Takafumi, et al. Nrf2 plays a critical role in the metabolic response during and after spaceflight. Communications Biology. 2021; 4 (1): 1381. doi:10.1038/s42003-021-02904-6 |
|
| 24. |
|
Yumoto Akane, Kokubo Toshiaki, Izumi Ryutaro, et al. Novel method for evaluating the health condition of mice in space through a video downlink. Experimental Animals. 2021; 70 (2): 236-244. doi:10.1538/expanim.20-0102 |
|